Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.
Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedSeveral key resources and links related to COVID-19 and pulmonary fibrosis have been removed, including important studies and government health websites.SummaryDifference5%
- Check41 days agoChange DetectedNew resources related to COVID-19 and pulmonary fibrosis have been added, including links to MedlinePlus and PubMed articles, which may be of particular interest to users monitoring health-related information.SummaryDifference0.7%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.